α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke.
about
Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke.Method parameters' impact on mortality and variability in rat stroke experiments: a meta-analysis.Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice.Treatment of cerebral ischemia with melanocortins acting at MC4 receptors induces marked neurogenesis and long-lasting functional recovery.Comparative analysis of a putative tuberculosis-susceptibility gene, MC3R, and pseudogene sequences in cattle, African buffalo, hyena, rhinoceros and other African bovids and ruminants.
P2860
α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@ast
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@en
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@nl
type
label
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@ast
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@en
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@nl
prefLabel
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@ast
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@en
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@nl
P2093
P2860
P356
P1476
α-MSH: a potential neuroprotec ...... t for the treatment of stroke.
@en
P2093
Anna V Savos
Dannielle Zierath
J Michael Gee
Kyra J Becker
P2860
P304
P356
10.1038/JCBFM.2010.130
P577
2010-08-11T00:00:00Z